Related Experiment Video
Updated: Aug 10, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines
W Wang1, L Heideman, C S Chung
1Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa 50011-1061, USA.
Abstract:
Apigenin, a common dietary flavonoid, has been shown to induce cell cycle arrest in both epidermal and fibroblast cells and inhibit skin tumorigenesis in murine models. The present study assessed the influence of apigenin on cell growth and the cell cycle in the human colon carcinoma cell lines SW480, HT-29, and Caco-2. Treatment of each cell line with apigenin (0-80 microM) resulted in a dose-dependent reduction in both cell number and cellular protein content, compared with untreated control cultures. DNA flow cytometric analysis indicated that treatment with apigenin resulted in G2/M arrest in all three cell lines in a time- and dose-dependent manner. Apigenin treatment (80 microM) for 48 h produced maximum G2/M arrest of 64%, 42%, and 26% in SW480 cells, HT-29 cells, and Caco-2 cells, respectively, in comparison with control cells (15%). The proportion of S-phase cells was not altered by apigenin treatment in each of the three cell lines. The G2/M arrest was reversible after 48 h of apigenin treatment in the most sensitive cell line SW480. The degree of G2/M arrest by apigenin was inversely correlated with the corresponding inhibition of cell growth measurements in all three cell lines (r = -0.626 to -0.917, P=0. 005). Moreover, an immune complex kinase assay demonstrated an inhibition of p34(cdc2) kinase activity, a critical enzyme in G2/M transition, in each cell line after treatment with apigenin (50-80 microM). Western blot analyses indicated that both p34(cdc2) and cyclin B1 proteins were also decreased after apigenin treatment. These results indicate that apigenin inhibits colon carcinoma cell growth by inducing a reversible G2/M arrest and that this arrest is associated, at least in part, with inhibited activity of p34(cdc2) kinase and reduced accumulation of p34(cdc2) and cyclin B1 proteins. Differences in induction of G2/M arrest by apigenin in the three colon carcinoma cell lines suggest that dietary apigenin may be differentially effective against tumors with specific mutational spectra. Mol. Carcinog. 28:102-110, 2000.
Insights
Apigenin, a dietary flavonoid, halts colon cancer cell growth by inducing a reversible G2/M cell cycle arrest. This effect is linked to reduced p34(cdc2) kinase activity and protein levels, suggesting differential efficacy against tumors.
Area of Science:
- Oncology
- Cell Biology
- Nutritional Science
Background:
- Apigenin, a common dietary flavonoid, exhibits anti-cancer properties, including cell cycle arrest and inhibition of skin tumorigenesis.
- Colon carcinoma is a significant health concern, necessitating research into novel therapeutic agents.
Purpose of the Study:
- To investigate the effects of apigenin on cell growth and the cell cycle in human colon carcinoma cell lines (SW480, HT-29, Caco-2).
- To elucidate the molecular mechanisms underlying apigenin's action on colon cancer cells.
Main Methods:
- Cell viability and protein content assays were performed following apigenin treatment.
- DNA flow cytometry was used to analyze cell cycle distribution.
- Immune complex kinase assays and Western blot analyses were conducted to assess protein activity and levels (p34(cdc2), cyclin B1).
Main Results:
- Apigenin caused a dose-dependent reduction in colon carcinoma cell number and protein content.
- Apigenin induced a reversible G2/M phase cell cycle arrest in all three cell lines.
- Apigenin inhibited p34(cdc2) kinase activity and decreased p34(cdc2) and cyclin B1 protein levels.
Conclusions:
- Apigenin inhibits colon carcinoma cell growth by inducing a reversible G2/M arrest, partly through the inhibition of p34(cdc2) kinase.
- The differential induction of G2/M arrest suggests apigenin may have varying effectiveness against colon tumors with different genetic profiles.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

